Editorial
Immune checkpoint inhibitors for non-small cell lung cancer patients on steroid or non-steroidal anti-inflammatory drugs treatment—therapeutic indication or therapeutic efficacy?
Translational Cancer Research
2022;
11
(9)
:3003-3005
.
(29 September 2022)
Double trouble: combined large-cell neuroendocrine and small-cell lung carcinoma
Translational Cancer Research
2022;
11
(9)
:3006-3011
.
(29 September 2022)
EBV and further emerging directions towards increased precision in gastric cancer treatment
Translational Cancer Research
2022;
11
(9)
:3012-3014
.
(29 September 2022)
Survival benefit of No. 10 lymphadenectomy with spleen preservation
Translational Cancer Research
2022;
11
(9)
:3015-3016
.
(29 September 2022)
Original Article
Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer
Translational Cancer Research
2022;
11
(9)
:3017-3023
.
(29 September 2022)
Efficacy of the No. 10 lymphadenectomy with spleen preservation on patients with gastric cancer and/or esophagogastric junction adenocarcinoma who underwent total gastrectomy: a systematic review and meta-analysis
Translational Cancer Research
2022;
11
(9)
:3024-3038
.
(29 September 2022)
Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer
Translational Cancer Research
2022;
11
(9)
:3039-3049
.
(29 September 2022)
Construction of a competing endogenous RNA network in head and neck squamous cell carcinoma by pan-cancer analysis
Translational Cancer Research
2022;
11
(9)
:3050-3063
.
(29 September 2022)
Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma
Translational Cancer Research
2022;
11
(9)
:3064-3079
.
(29 September 2022)
High expression of hypoxia-inducible factor 1-alpha predicts poor prognosis in pancreatic ductal adenocarcinoma: a meta-analysis and database validation protocol
Translational Cancer Research
2022;
11
(9)
:3080-3091
.
(29 September 2022)
Thematic trends and knowledge structure map of sentinel lymph node biopsy for breast cancer: a bibliometric analysis from 2010 to 2019
Translational Cancer Research
2022;
11
(9)
:3092-3107
.
(29 September 2022)
Genomic analysis of the endosomal sorting required for transport complex III pathway genes as therapeutic and prognostic biomarkers for endometrial carcinoma
Translational Cancer Research
2022;
11
(9)
:3108-3127
.
(29 September 2022)
A nomogram and risk classification model predicts prognosis in Chinese esophageal squamous cell carcinoma patients
Translational Cancer Research
2022;
11
(9)
:3128-3140
.
(29 September 2022)
Prognostic factors and individualized nomograms predicting overall survival in stage IV rectal cancer patients with different metastatic status: a SEER-based study
Translational Cancer Research
2022;
11
(9)
:3141-3155
.
(29 September 2022)
Development and validation of an online prognostic nomogram for osteosarcoma after surgery: a retrospective study based on the SEER database and external validation with single-center data
Translational Cancer Research
2022;
11
(9)
:3156-3174
.
(29 September 2022)
A newly identified pyroptosis-related gene signature for predicting prognosis of patients with hepatocellular cancer
Translational Cancer Research
2022;
11
(9)
:3175-3186
.
(29 September 2022)
A comprehensive pan-cancer analysis on the immunological role and prognostic value of TYMP in human cancers
Translational Cancer Research
2022;
11
(9)
:3187-3208
.
(29 September 2022)
High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer
Translational Cancer Research
2022;
11
(9)
:3209-3221
.
(29 September 2022)
Expression and clinical significance of FGFR1 and FGFR2 in laryngeal squamous cell carcinoma
Translational Cancer Research
2022;
11
(9)
:3222-3234
.
(29 September 2022)
Screening and verification of prognostic lncRNA markers related to immune infiltration in the metastasis of osteosarcoma
Translational Cancer Research
2022;
11
(9)
:3235-3249
.
(29 September 2022)
Effects of Shu Bu Wenshen Guchang recipe on intestinal injury and the TLR4/NF-κB signaling pathways in mice with irinotecan-induced delayed-type diarrhea
Translational Cancer Research
2022;
11
(9)
:3250-3259
.
(29 September 2022)
The short-term outcomes for the early removal of pigtail catheter drainage within 24 hours of uniportal video-assisted anatomic surgery in patients with lung cancer
Translational Cancer Research
2022;
11
(9)
:3260-3266
.
(29 September 2022)
Transrectal endoscopic ultrasound-guided fine-needle aspiration biopsy for qualitative diagnosis of pelvic space-occupying lesions: a diagnostic test
Translational Cancer Research
2022;
11
(9)
:3267-3276
.
(29 September 2022)
ThinPrep cytologic test combined with HPV typing to evaluate the degree of cervical diseases and the relationship between HPV typing and the pathological results of patients with atypical squamous cells of undetermined significance: a diagnostic test
Translational Cancer Research
2022;
11
(9)
:3277-3286
.
(29 September 2022)
Network pharmacology analysis of the mechanism of Huisheng oral liquid in the treatment of lung cancer
Translational Cancer Research
2022;
11
(9)
:3287-3297
.
(29 September 2022)
Review Article
Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?—a narrative review by the international geriatric radiotherapy group
Translational Cancer Research
2022;
11
(9)
:3298-3308
.
(29 September 2022)
Case Report
Infliximab in the treatment of tislelizumab-induced steroid-refractory immune checkpoint inhibitor-related pneumonia: case report and literature review
Translational Cancer Research
2022;
11
(9)
:3309-3314
.
(29 September 2022)
Misdiagnosis of primary mucosa-associated lymphoid tissue lymphoma of the pleura: case report and literature review
Translational Cancer Research
2022;
11
(9)
:3315-3321
.
(29 September 2022)
Determination of the best surgical strategy for thoracic esophageal resection concurrent with double aortic arch using a three-dimensional model: a case report
Translational Cancer Research
2022;
11
(9)
:3322-3328
.
(29 September 2022)
Successful outcome of neoadjuvant PD-1 blockade, VEGFR-2 inhibitor plus chemotherapy for potentially unresectable esophagogastric junctional squamous cell carcinoma: a case report
Translational Cancer Research
2022;
11
(9)
:3329-3336
.
(29 September 2022)
Intracranial complete response to toripalimab and anlotinib in a patient with recurrent brain metastases of small cell lung cancer after failure of second-line maintenance therapy: a case report
Translational Cancer Research
2022;
11
(9)
:3337-3342
.
(29 September 2022)
Advanced lung adenocarcinoma (LUAD) patient with EGFR mutations benefited from multiline combination targeted therapies after osimertinib (AZD9291) resistance: a case report
Translational Cancer Research
2022;
11
(9)
:3343-3348
.
(29 September 2022)
Leptomeningeal metastasis from de novo metastatic nasopharyngeal carcinoma: a case report
Translational Cancer Research
2022;
11
(9)
:3349-3356
.
(29 September 2022)
Advanced non-small cell lung cancer treated with palliative systemic therapy complicated by calvarial metastasis: a case report
Translational Cancer Research
2022;
11
(9)
:3357-3362
.
(29 September 2022)
Primary mesenchymal chondrosarcoma of the adult lumbar spine: a case report and review of the literature
Translational Cancer Research
2022;
11
(9)
:3363-3370
.
(29 September 2022)
Rare malignant primary spinal intradural extramedullary mesenchymal chondrosarcoma: a case report and literature review
Translational Cancer Research
2022;
11
(9)
:3371-3378
.
(29 September 2022)
A recurrent inflammatory myofibroblastic tumor patient with two novel ALK fusions: a case report
Translational Cancer Research
2022;
11
(9)
:3379-3384
.
(29 September 2022)
Perioperative management of intrahepatic cholangiocarcinoma patients with hereditary coagulation factor V deficiency: a case report and literature review
Translational Cancer Research
2022;
11
(9)
:3385-3390
.
(29 September 2022)
Ovarian metastases from ALK-positive lung adenocarcinoma: a case report and review of the literature
Translational Cancer Research
2022;
11
(9)
:3391-3399
.
(29 September 2022)
Radiation induced lung injury (RILI) after postoperative intensity modulated proton therapy (IMPT) in a patient with stage III locally advanced lung adenocarcinoma: a case report
Translational Cancer Research
2022;
11
(9)
:3400-3408
.
(29 September 2022)
CT and MRI findings of intracranial extraskeletal mesenchymal chondrosarcoma—a case report and literature review
Translational Cancer Research
2022;
11
(9)
:3409-3415
.
(29 September 2022)
Pembrolizumab for treatment of a male with primary mediastinal choriocarcinoma: a case report
Translational Cancer Research
2022;
11
(9)
:3416-3420
.
(29 September 2022)
Endometrial stromal sarcoma metastatic to the inferior vena cava: a case report and literature review
Translational Cancer Research
2022;
11
(9)
:3421-3425
.
(29 September 2022)
Intradural spinal seeding metastasis of clival chordoma: a case report
Translational Cancer Research
2022;
11
(9)
:3426-3433
.
(29 September 2022)
Primary hepatic paraganglioma mimicking hepatocellular carcinoma: a case report
Translational Cancer Research
2022;
11
(9)
:3434-3439
.
(29 September 2022)
